Trial Profile
Dose finding Phase 2a Study of Inecalcitol in Combination with Standard Docetaxel Prednisone Regimen in Hormone-Refractory Prostate Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Dec 2023
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Inecalcitol (Primary) ; Prednisone (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Adverse reactions
- Sponsors ATON; Hybrigenics
- 29 Jan 2019 According to a Hybrigenics company website, the study is led by the medical oncology department at the Georges Pompidou Hospital, Paris.
- 25 Jul 2011 New trial record
- 31 May 2011 Final results were reported at the Annual Meeting of the American Society of Clinical Oncology (ASCO-2011).